Ozarelix
- Generic Name
- Ozarelix
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C72H96ClN17O14
- CAS Number
- 295350-45-7
- Unique Ingredient Identifier
- Q1IF8M2YL3
- Background
Ozarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath